Phreesia, Inc.

XNYSIndustrials

Last traded price · USD

$13.19

+0.08%Delayed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:43 IST · A quote does not mean the product is available to trade on your account.

Day's open: $13.30
Previous close: $13.18
Volume: 56,149
Day's high: $13.39
Day's low: $13.14

In brief

Phreesia, Inc. is an industrials company listed on the New York Stock Exchange, valued at about $819M.
Its shares closed at $13.18 on 4 Nov 2026, down 41.5% over the past year.
From India you can buy PHR in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Phreesia, Inc. (PHR) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole PHR share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade PHR options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLI over 1 year
1 month: +28.6% (SPY −1.6%, XLI −1.2%). 3 months: +14.7% (SPY −0.4%, XLI −9.1%). 1 year: −41.5% (SPY +13.6%, XLI +11.0%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PHR, SPY and XLI · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $13.18 was 18.8% above its 50-day average ($11.09) and 21.2% above its 200-day average ($10.87). It has closed above the 200-day for 13 sessions, since 19 Oct 2026. The 50-day average crossed above the 200-day on 27 Oct 2026, 6 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
5.1 days to cover short interest
3.1M shares were sold short at the 15 Oct 2026 settlement, 5.0% of the 62.1M shares outstanding; covering them would take 5.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
RSI(14) at 72.3, 70 or above
The 14-session relative strength index closed at 72.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
35% of the way up its 52-week range
Closed at $13.18 on 4 Nov 2026: 43.4% below the 52-week high of $23.31 (12 Nov 2025) and 69.6% above the low of $7.77 (31 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+28.6%

6 months+38.3%

1 year−41.5%

5 years−82.3%

Newswire

About

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

Website

Notable moves

March 31, 2026
−26.56%
December 9, 2025
−23.31%
September 7, 2023
−22.11%

Newswire

About

Website

Notable moves

March 31, 2026
−26.56%
December 9, 2025
−23.31%
September 7, 2023
−22.11%

Phreesia, Inc.

XNYSIndustrials

Last traded price · USD

$13.19

+0.08%Delayed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:43 IST · A quote does not mean the product is available to trade on your account.

Day's open: $13.30
Previous close: $13.18
Volume: 56,149
Day's high: $13.39
Day's low: $13.14

In brief

Phreesia, Inc. is an industrials company listed on the New York Stock Exchange, valued at about $819M.
Its shares closed at $13.18 on 4 Nov 2026, down 41.5% over the past year.
From India you can buy PHR in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Phreesia, Inc. (PHR) shares from India?

Do I need the price of a whole PHR share to invest?

How much can I invest in US stocks in a year?

Can I trade PHR options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLI over 1 year
1 month: +28.6% (SPY −1.6%, XLI −1.2%). 3 months: +14.7% (SPY −0.4%, XLI −9.1%). 1 year: −41.5% (SPY +13.6%, XLI +11.0%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PHR, SPY and XLI · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $13.18 was 18.8% above its 50-day average ($11.09) and 21.2% above its 200-day average ($10.87). It has closed above the 200-day for 13 sessions, since 19 Oct 2026. The 50-day average crossed above the 200-day on 27 Oct 2026, 6 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
5.1 days to cover short interest
3.1M shares were sold short at the 15 Oct 2026 settlement, 5.0% of the 62.1M shares outstanding; covering them would take 5.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
RSI(14) at 72.3, 70 or above
The 14-session relative strength index closed at 72.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
35% of the way up its 52-week range
Closed at $13.18 on 4 Nov 2026: 43.4% below the 52-week high of $23.31 (12 Nov 2025) and 69.6% above the low of $7.77 (31 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+28.6%

6 months+38.3%

1 year−41.5%

5 years−82.3%

Newswire

About

Website

Notable moves

March 31, 2026
−26.56%
December 9, 2025
−23.31%
September 7, 2023
−22.11%

Newswire

About

Website

Notable moves

March 31, 2026
−26.56%
December 9, 2025
−23.31%
September 7, 2023
−22.11%

Phreesia, Inc.

Phreesia, Inc. in brief

Behind SPY and its sector fund XLI over 1 year

Above its 50- and 200-day averages

5.1 days to cover short interest

RSI(14) at 72.3, 70 or above

35% of the way up its 52-week range

Phreesia, Inc.

Phreesia, Inc. in brief

Behind SPY and its sector fund XLI over 1 year

Above its 50- and 200-day averages

5.1 days to cover short interest

RSI(14) at 72.3, 70 or above

35% of the way up its 52-week range